Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FluLaval Quadrivalent Efficacy in Children
NCT01218308Phase 3Completed
- Sponsor
- GSK
- Start
- Dec 2010
- Primary completion
- Jan 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 8
01
Overview
Phase 3, randomised, double-blind trial of influenza virus vaccine, quadrivalent, split virion in influenza (2 arms), sponsored by GSK. Primary endpoint: Number of Subjects Reporting at Least One Confirmed Occurrence of Influenza A or B. Started Dec 2010; status: completed.
02
Drugs
influenza virus vaccine, quadrivalent, split virion
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01218308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01218308.